Well folks, here I go again!! A new trial!!
CX-5461
Phase 1 study to find the right dose of CX-5461 and to look at what effects CX-5461 have in patients with solid tumours with BRCA2 and/or PARB2 mutations
Cancers included in the study: pancreatic, ovarian, prostate and breast cancer
First, although I do not have one of the two mutations identified in the title, I do have a mutation, NBN, that is included in the main group of this study. A special shout out to the Fellow who was working the day I went in to explore trials!! I was already assigned this trial, but he recognized the mutation and went to confirm that it was, indeed, a mutation being explored for this trial. I have to say, it provided some relief to know that I had two specific things for this trial.
This is a phase 1B study so it is still in the early phase and does not mean the drug will target the mutation but at least it is being explored and may help those that come behind me. On a more positive note - and with "hope" - the drug may be exactly what I need!!
I am just moving through the screening process now and will continue to journal my experience.